Ljones, 8 July 2024: Reference is made to the warrants (the "Warrants") issued in connection with the private placement completed by Biofish Holding AS (the “Company”) in January 2023 (the "Private Placement") and the subsequent offering (the "Subsequent Offering") and resolved by the extraordinary general meeting of the Company held on 23 January 2023.
Shareholders that have been allocated Warrants have the third opportunity to exercise the Warrants in the period starting on 8 July 2024 and expiring on 9 August 2024 (the "Third Exercise Period").
A letter describing the process, including the exercise notice form, is being sent to each holder of Warrants.
Any questions may be directed to Fearnley Securities AS: tel: +47 22 93 60 00, e-mail: bfish-wts@fearnleys.com.
For additional information please contact:
Johnny Duedahl, CFO
Mob: +47 982 06 833 Email: johnny@biofish.no
About BioFish
BioFish is a Norwegian independent producer of high-quality smolt and post-smolt. The company has a post-smolt RAS production facility in Ljones close to the Hardangerfjord on the west coast of Norway. Almost 40 per cent of Norwegian fish farming sites are located within one day of transport.
We use cookies to provide you with the best experience on our website. Some cookies are necessary for the site to function, while others help us analyze website usage and personalize content and ads. You can choose to accept all, only necessary cookies, or customize your preferences. Read our privacy policy for more information.
Essential cookies and services enable basic functions and are necessary for the proper functioning of the website. These cookies and services do not require user permission according to GDPR.
This category includes all cookies, domains, and services that do not fall into the other specified categories or have not been explicitly categorized.
We use cookies to enhance your experience. Some are necessary, while others help us with analytics and personalization. You can adjust your settings at any time. Read our privacy policy for more information.